Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00991419 · ClinicalTrials.gov registry record · Phase 2
To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden
A Phase 2 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT00991419: Completed Phase 2 study, sponsored by AstraZeneca.
NCT00991419 is a Phase 2 study that has completed, run by AstraZeneca. The registered enrollment target is 25 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00991419, a Phase 2 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to compare PET measurements of fibrillar amyloid burden using \[18F\]AZD4694.
Interventions
- DRUG [18F]AZD4694
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-08 |
| Phase | Phase 2 |
What the finished NCT00991419 record still lists
NCT00991419 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 1 intervention - of which [18F]AZD4694 is the first listed.
NCT00991419 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00991419 about?
NCT00991419 is a clinical study titled "To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden". The purpose of this study is to compare PET measurements of fibrillar amyloid burden using \[18F\]AZD4694.
What is the current status of trial NCT00991419?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2010-02. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00991419?
The interventions under investigation include: [18F]AZD4694 (DRUG).
Who is sponsoring clinical trial NCT00991419?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00991419's enrollment target sits among peer trials
25 1719th of 2000 higher than 245 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia